Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pulmonary tuberculosis reactivation following ruxolitinib treatment in a patient with primary myelofibrosis.

× No keyword cloud information.

8 in total

1. Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms.

Authors: Junshik Hong; Ju Hyun Lee; Ja Min Byun; Ji Yun Lee; Youngil Koh; Dong-Yeop Shin; Jeong-Ok Lee; Sang Mee Hwang; Hyoung Soo Choi; Inho Kim; Sung-Soo Yoon; Soo-Mee Bang
Journal: Blood Adv Date: 2019-11-26

2. Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.

Authors: Norio Komatsu; Keita Kirito; Kazuya Shimoda; Takayuki Ishikawa; Kohshi Ohishi; Kazuma Ohyashiki; Naoto Takahashi; Hikaru Okada; Taro Amagasaki; Toshio Yonezu; Koichi Akashi
Journal: Int J Hematol Date: 2016-11-10 Impact factor: 2.490

3. Tuberculosis in Patients with Primary Myelofibrosis During Ruxolitinib Therapy: Case Series and Literature Review.

Authors: Yizhou Peng; Li Meng; Xuemei Hu; Zhiqiang Han; Zhenya Hong
Journal: Infect Drug Resist Date: 2020-09-28 Impact factor: 4.003

4. Ruxolitinib Associated Tuberculosis Presenting as a Neck Lump.

Authors: Eamon Shamil; David Cunningham; Billy L K Wong; Piyush Jani
Journal: Case Rep Infect Dis Date: 2015-12-15

5. Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib.

Authors: Maheen Z Abidi; Javeria Haque; Parvathi Varma; Horatiu Olteanu; Guru Subramanian Guru Murthy; Binod Dhakal; Parameswaran Hari
Journal: Case Rep Hematol Date: 2016-10-23

6. Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor.

Authors: Palma Manduzio
Journal: Ther Clin Risk Manag Date: 2017-02-13 Impact factor: 2.423

Review 7. Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature.

Authors: Yasuhiro Tsukamoto; Junichi Kiyasu; Mariko Tsuda; Motohiko Ikeda; Motoaki Shiratsuchi; Yoshihiro Ogawa; Yuji Yufu
Journal: Intern Med Date: 2017-12-27 Impact factor: 1.271

Review 8. The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms.

Authors: Mads Emil Bjørn; Hans Carl Hasselbalch
Journal: Mediators Inflamm Date: 2015-10-11 Impact factor: 4.711

8 in total